home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

LOX Stops The Spread

  May, 10 2006 13:03
your information resource in human molecular genetics
Most deaths from cancer occur because of metastasis - when tumour cells spread throughout the body. In the 27 April 2006 issue of Nature (Vol. 440, No. 7088, p. 1222-1226), Amato Giaccia and colleagues identify a protein vital for metastasis that could be a new target for cancer therapies.

Tumours contain areas low in oxygen in which the cells are - for unknown reasons - particularly prone to metastatic growth. The team shows that the enzyme lysyl oxidase (LOX) is produced at high levels in oxygen-starved human breast, head and neck tumours, and that patients with tumours producing high levels of LOX are more likely to suffer metastasis and tend to survive for shorter periods.

The group also shows that LOX promotes metastasis by helping cells migrate into and invade new tissue, and that inhibiting the LOX enzyme blocks metastasis of breast cancer in a mouse model.


Amato Giaccia (Stanford University School of Medicine, Stanford, CA, USA)
E-mail: giaccia@stanford.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.